Bluesight and Medacist provide medication management and drug diversion software platforms for more than 2,000 hospitals in the U.S. Bluesight has raised nearly $50 million, including from the venture capital arms of Oakland, Calif.-based Kaiser Permanente and Raleigh, N.C.-based UNC Health Rex (Rex Health Ventures).
“Technological advancements, including artificial intelligence, are digitizing healthcare and driving demand for software innovations in medication management,” said Bluesight co-founder and CEO Kevin MacDonald, who will lead the combined company, in a July 17 news release. “Health system pharmacies are looking for solutions that lower costs, increase efficiency, and improve compliance.”
Terms of the deal were not disclosed.
